<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01548352</url>
  </required_header>
  <id_info>
    <org_study_id>BASEL IX</org_study_id>
    <nct_id>NCT01548352</nct_id>
  </id_info>
  <brief_title>BAsel Syncope EvaLuation (BASEL IX) Study</brief_title>
  <official_title>BAsel Syncope EvaLuation (BASEL IX) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss National Science Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Syncope is a major health problem. In the emergency department (ED), the management of&#xD;
      patients with syncope still remains a clinical challenge because underlying diseases and&#xD;
      prognosis can be extremely various. Structural heart disease and primary electrical disorders&#xD;
      are major risk factors for sudden cardiac death and mortality in patients with syncope. In&#xD;
      contrast, patients with reflex syncope and exclusion of structural heart disease have an&#xD;
      excellent prognosis.&#xD;
&#xD;
      Therefore The investigators test the hypothesis that the use of a meticulous patient history,&#xD;
      clinical examination and novel biomarkers can improve the rapid and accurate diagnosis of&#xD;
      cardiac syncope in patients presenting to the ED and is able to improve risk stratification&#xD;
      regarding adverse outcomes.&#xD;
&#xD;
      The prospective multicenter cohort study is designed to enroll 720 patients presenting with&#xD;
      transient loss of consciousness within the last 12 hours to the ED. Blood samples for the&#xD;
      measurement of novel biomarkers will be obtained at presentation.&#xD;
&#xD;
      All patients will be contacted by phone at 6, 12 and 24 months to determine major adverse&#xD;
      events (death, resuscitation, recurrence of syncope, hospitalization for syncope).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Management of patients with syncope is a serious problem concerning 1-2% of&#xD;
      emergency department (ED) visits. In 6-20% of these, syncope will be due to a cardiac origin.&#xD;
      The rapid and accurate identification of these patients is an important unmet clinical need.&#xD;
&#xD;
      Aim: The aim of the study is to evaluate the diagnostic value of patient's history, clinical&#xD;
      judgement and novel biomarkers, alone or in combination, in the diagnosis and risk&#xD;
      stratification of patients &gt; 40 years of age presenting with syncope to the ED.&#xD;
&#xD;
      Patients and Methods: This prospective, observational, international multicenter study is&#xD;
      initially designed to enroll 720 adult patients &gt; 40 years presenting to the ED with syncope&#xD;
      within the last twelve hours. Patient history will be standardized using a predefined form.&#xD;
      Treating physicians will be asked to quantify their clinical judgment regarding the presence&#xD;
      of cardiac syncope. Digital 12-lead ECG will be recorded at presentation and stored&#xD;
      electronically. Blood samples for the measurement of novel cardiovascular biomarkers&#xD;
      (including copeptin, pro-endothelin-1, pro-adrenomedullin, natriuretic peptides and&#xD;
      high-sensitive cardiac troponins) will be obtained at presentation and stored anonymized.&#xD;
      Patients will be contacted by phone at 6, 12 and 24 months to determine major adverse events&#xD;
      (death, resuscitation, recurrence of syncope, hospitalization for syncope) and results of&#xD;
      follow-up examinations. The final diagnosis will be adjudicated by two independent experts&#xD;
      after review of all documents pertaining to the individual patient after 6 months. The&#xD;
      primary endpoint is to assess the performance of a standardized form of patient's history,&#xD;
      clinical judgment and biomarkers, alone and in combination, in the diagnosis of a cardiac&#xD;
      syncope, as adjudicated by two independent experts. Secondary endpoints include the accuracy&#xD;
      of the above cited items in prognostic stratification and the determination of the&#xD;
      cost-effectiveness of the best approach.&#xD;
&#xD;
      Clinical significance: A more accurate and more rapid diagnosis and risk stratification of&#xD;
      cardiac syncope can significantly improve patient management and therefore reduce patient&#xD;
      morbidity and treatment cost. Overall, we expect this study to provide novel insights,&#xD;
      holding important scientific, clinical and economic implications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic and prognostic value of various novel and established biomarkers, clinical assessment and detailed patient history</measure>
    <time_frame>within 24 months</time_frame>
    <description>To test the diagnostic performance of predefined elements of a standardized patient history, overall clinical judgement using a visual analogue scale, and novel biomarkers in the diagnosis of cardiac syncope in patients presenting to the ED.</description>
  </primary_outcome>
  <enrollment type="Anticipated">3500</enrollment>
  <condition>Syncope</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      EDTA Plasma; Heparin; Serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting to the emergency department with syncope within the last 12 hours.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients presenting to the emergency department&#xD;
&#xD;
          -  Age &gt; 40 years&#xD;
&#xD;
          -  Syncope within the last 12 hours&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 40 years&#xD;
&#xD;
          -  Patients without loss of consciousness and with certain neurological causes (e.g.&#xD;
             recurrent epilepsy, hemiplegia at presentation)&#xD;
&#xD;
          -  No written informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Mueller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Cardiovascular de Buenos Aires</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1428</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Women's hospital</name>
      <address>
        <city>Brisbane</city>
        <zip>QLD 4029</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Nürnberg</name>
      <address>
        <city>Nürnberg</city>
        <state>Bavaria</state>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sant'Andrea Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christchurch Hospital</name>
      <address>
        <city>Christchurch</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of Silesia</name>
      <address>
        <city>Zabrze</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic of Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Baselland</name>
      <address>
        <city>Liestal</city>
        <state>Baselland</state>
        <zip>4410</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spital Lachen</name>
      <address>
        <city>Lachen</city>
        <state>Schwyz</state>
        <zip>8853</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Luzern Kantonsspital</name>
      <address>
        <city>Luzern</city>
        <zip>6000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>New Zealand</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Belgium</country>
    <country>Czech Republic</country>
    <country>Czechia</country>
  </removed_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 5, 2012</study_first_submitted>
  <study_first_submitted_qc>March 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2012</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Basel, Switzerland</investigator_affiliation>
    <investigator_full_name>Christian Müller, MD</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>Syncope</keyword>
  <keyword>Unconsciousness</keyword>
  <keyword>Syncope, vasovagal, neurally-mediated</keyword>
  <keyword>Syncope, cardiogenic</keyword>
  <keyword>Cardiac arrhythmia</keyword>
  <keyword>Sudden cardiac death</keyword>
  <keyword>Syncopal episode</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syncope</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

